Physician profile
Scott A Reishus
NPI 1245210160
$9,616.46
in general payments reported to CMS, 2019-2025
31 companies · $1,317 in 2025
The $1,317 reported for 2025 was more than what a typical Vascular Surgery provider received nationally (typical 2025 total: $927).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $1,304 · 2020: $1,785 · 2021: $470 · 2022: $452 · 2023: $2,173 · 2024: $2,116 · 2025: $1,317.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,126 · Consulting Fee: $1,650 · Travel and Lodging: $830.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,126.28 |
| Consulting Fee | $1,650.00 |
| Travel and Lodging | $829.74 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Silk Road Medical, INC. | $2,765.86 | 2019-2024 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent, Enroute Enflate Transcarotid Rx Balloon Dilatation Catheter |
| W. L. Gore & Associates, INC. | $2,031.70 | 2019-2025 | Excluder Conformable Aaa Endoprosthesis With Active Control, Gore Tag Thoracic Branch Endoprosthesis, Gore Excluder Thoracoabdominal Branch Endoprosthesis |
| Bard Peripheral Vascular, INC. | $846.76 | 2019-2025 | Rotarexs 6 F X 135 Cm |
| Medtronic USA, INC. | $462.95 | 2020 | |
| Covidien LP | $453.41 | 2019 | |
| Medtronic, INC. | $430.47 | 2021-2025 | Anteralign Spinal System With Titan Nanolock Surface Technology, Sonicision, Hawkone |
| Atrium Medical Corporation | $400.00 | 2025 | Flixene |
| Janssen Pharmaceuticals, INC | $318.47 | 2021-2022 | |
| Stryker Corporation | $293.30 | 2025 | Artix Mt, Limflow System, Venacore Thrombectomy Catheter |
| Lemaitre Vascular, INC. | $265.16 | 2020-2025 | Hydro Lemaitre Valvulotome, Artegraft Vascular Graft, Tyke, Patch, Pledget and Intracardiac |
| Integra Lifesciences Corporation | $206.63 | 2022-2023 | Integra, Primatrix, Integra Dermal Regeneration Template |
| Cvrx, INC. | $188.71 | 2021-2025 | Barostim Neo System |
| Boston Scientific Corporation | $161.47 | 2023 | Eluvia |
| Imperative Care, INC | $152.46 | 2025 | Prodigy Catheter |
| Davol INC. | $102.03 | 2019 |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Chiesi USA, INC. | $83.66 | 2019-2022 | |
| Kerecis Limited | $69.99 | 2024 | Kerecis Omega3 Marigen, Kerecis Omega3 Graftguide, Kerecis Omega3 Surgiclose |
| Intuitive Surgical, INC. | $59.43 | 2023 | Da Vinci Surgical System |
| Becton, Dickinson and Company | $42.22 | 2019-2024 | Denali Vena Cava Filter |
| Innovation Technologies INC | $41.67 | 2021 | |
| Smith+Nephew, INC. | $38.65 | 2019 | |
| Misonix INC | $25.36 | 2020 | |
| Osiris Therapeutics INC. | $24.46 | 2019 | |
| Abbott Laboratories | $23.60 | 2025 | Perclose Prostyle |
| Tactile Systems Technology INC | $22.85 | 2019 | |
| Cordis US Corp. | $22.50 | 2025 | Mynx Control Venous |
| Avinger INC. | $22.42 | 2023 | Pantheris |
| Biocompatibles, INC. | $18.12 | 2019 | |
| Paratek Pharmaceuticals, INC. | $18.05 | 2021 | |
| Ethicon US, LLC | $16.87 | 2021 | |
| Cardiovascular Systems INC. | $7.23 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Scott Reishus listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
The CSV has this whole record: totals, yearly figures, every listed company, payment types, and product associations.
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.